from Reuters: Health News https://ift.tt/2yGdGIK
Novartis, Pfizer join forces on potentially lucrative fatty liver disease
Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics.
from Reuters: Health News https://ift.tt/2yGdGIK
from Reuters: Health News https://ift.tt/2yGdGIK
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment